Skip to main content

Articles

Page 3 of 6

  1. Arterial stiffness is associated with myocardial ischemia and incident coronary artery disease (CAD), and indexes of arterial stiffness are usually increased in patients with CAD. However, these indexes are of...

    Authors: Seong Taeg Kim, Yeekyoung Ko, Jong-Wook Beom, Ki Yung Boo, Jae-Geun Lee, Joon-Hyouk Choi, Song-Yi Kim and Seung-Jae Joo
    Citation: Clinical Hypertension 2021 27:5
  2. BENEFIT-KOREA (BEnefits after 24 weeks of NEbivolol administration For essential hypertensIon patients wiTh various comorbidities and treatment environments in Korea) study, an observational study in South Kor...

    Authors: Kyoung Im Cho, Dong Woon Jeon, Hyo Seung Ahn, Dong Kyu Jin, Hyun Sang Lee, Jong-Young Lee, Hong-Seok Lim, Athanasios J. Manolis, Seung-Woon Rha and Sang Won Park
    Citation: Clinical Hypertension 2021 27:9
  3. The Korean Society of Hypertension has published the Korea Hypertension Fact Sheet 2020 to provide an overview of the magnitude and management status of hypertension and their recent trends.

    Authors: Hyeon Chang Kim, So Mi Jemma Cho, Hokyou Lee, Hyeok-Hee Lee, Jongmin Baek and Ji Eun Heo
    Citation: Clinical Hypertension 2021 27:8

    The Correction to this article has been published in Clinical Hypertension 2021 27:10

  4. It is known in some studies that higher the LDL-C, the greater the risk of developing cardiovascular disease. However, studies of the causal effects between LDL-C and hypertension are limited by their observat...

    Authors: Tae-Hwa Go, Kyeong Im Kwak, Ji-Yun Jang, Minheui Yu, Hye Sim Kim, Jang Young Kim, Sang Baek Koh and Dae Ryong Kang
    Citation: Clinical Hypertension 2021 27:7
  5. Previous studies that investigated association of height with prevalence and control of hypertension found mixed results. This cross-sectional study explored these associations among US adults (≥20 years).

    Authors: Rajat Das Gupta, Maxwell Akonde, Ibrahim Hossain Sajal and Gulam Muhammed Al Kibria
    Citation: Clinical Hypertension 2021 27:6
  6. Smartphone technology has spread rapidly around the globe. According to a report released by the Korea Information Society Development Institute, about 95% of Koreans aged more than 30 years old owned smartpho...

    Authors: Hae Young Lee, Dong-Ju Lee, Jongmo Seo, Sang-Hyun Ihm, Kwang-il Kim, Eun Joo Cho, Hyeon Chang Kim, Jinho Shin, Sungha Park, Il-Suk Sohn, Wook-Jin Chung, Sung Kee Ryu, Ki Chul Sung, Juhan Kim, Dae-Hee Kim and Wook Bum Pyun
    Citation: Clinical Hypertension 2021 27:4
  7. Hypertension, the most common comorbidity among coronavirus disease 2019 (COVID-19) patients, is accompanied by worse clinical outcomes, but there is lack of evidence about prognostic factors among COVID-19 pa...

    Authors: Ramin Hosseinzadeh, Mohammad Ali Sheikh Beig Goharrizi, Mansour Bahardoust, Akbar Ghorbani Alvanegh, Mohammad Reza Ataee, Mehdi Bagheri, Ensiyeh Shabani Navidiyan, Seyed Reza Hosseini Zijoud and Mohammad Heiat
    Citation: Clinical Hypertension 2021 27:3
  8. High dietary salt and a lack of reduced blood pressure (BP) at night (non-dipping) are risk factors for the development of hypertension which may result in end-organ damage and death. The effect of high dietar...

    Authors: Sepiso K. Masenga, Annet Kirabo, Benson M. Hamooya, Selestine Nzala, Geoffrey Kwenda, Douglas C. Heimburger, Wilbroad Mutale, John R. Koethe, Leta Pilic and Sody M. Munsaka
    Citation: Clinical Hypertension 2021 27:2
  9. Hypertension is a major public health problem and a prominent risk factor for cardiovascular diseases. However, whether passive smoking exposure (PSE) is associated with the risk of hypertension is scarcely un...

    Authors: Onoja Matthew Akpa, Akinkunmi Paul Okekunle, Jeffery Osahon Asowata and Babatunde Adedokun
    Citation: Clinical Hypertension 2021 27:1
  10. Although recent hypertension guidelines recommend home blood pressure (HBP) monitoring, its effect in clinical practice is not well known. This study aimed to identify current HBP measurement status and obstac...

    Authors: Jung-Yeon Choi, Kwang-il Kim and Cheol-Ho Kim
    Citation: Clinical Hypertension 2020 26:24
  11. Globally hypertension in adults is among the leading preventable cause of premature death, where a graded association from the childhood hypertension is well recognised. With the concurrent rise in obesity and...

    Authors: Mohd Ashraf, Mohd Irshad and Nazir Ahmed Parry
    Citation: Clinical Hypertension 2020 26:22
  12. According to the last Hypertension guideline recommendations, it may be concluded that intensive BP lowering is only advisable in a subgroup of patients where there is a clear net benefit of targeting to lower...

    Authors: Miguel Camafort, Josep Redón, Wook Bum Pyun and Antonio Coca
    Citation: Clinical Hypertension 2020 26:21
  13. The risk associated with serum uric acid (SUA) levels when within the normal range is unknown. This study aims to examine whether SUA within the normal range is a predictor of hypertension.

    Authors: Ryuichi Kawamoto, Daisuke Ninomiya, Taichi Akase, Kikuchi Asuka and Teru Kumagi
    Citation: Clinical Hypertension 2020 26:20
  14. This study was aimed at determining the levels of serum adiponectin, leptin, resistin, visfatin and lipids during the first trimester in pregnant women and to evaluate the relationship between these biochemica...

    Authors: Ahmed Tijani Bawah, Francis Agyemang Yeboah, Salifu Nanga, Huseini Alidu and Robert A. Ngala
    Citation: Clinical Hypertension 2020 26:19
  15. Pulmonary thromboembolism (PTE) is thought to usually stem from deep vein thrombosis (DVT). However, evidence of DVT could not be found in many cases. Furthermore, transient thyrotoxicosis is a rare but potent...

    Authors: Tong-Yoon Kim, Sang-Hyun Ihm, Ji Woong Roh, Sungmin Lim, Chan-Seok Park and Hee-Yeol Kim
    Citation: Clinical Hypertension 2020 26:17
  16. Preeclampsia is a complex syndrome that is considered a disorder specific to pregnancy. However, research indicates that diffuse maternal endothelial damage may persist after childbirth. On the other hand, wom...

    Authors: Kassahun Fikadu, Feleke G/Meskel, Firdawek Getahun, Nega Chufamo and Direslign Misiker
    Citation: Clinical Hypertension 2020 26:16
  17. Chronic kidney disease (CKD) is a significant comorbidity among hypertensive patients. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) have been demonstrated to be significantly associated wit...

    Authors: William K. B. A. Owiredu, Michael Appiah, Christian Obirikorang, Evans Asamoah Adu, Vincent Boima, Ernestine Kubi Amos-Abanyie, Priscilla Abena Akyaw, Eddie-Williams Owiredu and Emmanuel Acheampong
    Citation: Clinical Hypertension 2020 26:15
  18. There is current debate concerning the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers (ARBs), for hypertension management, during COVID-19 infection. Specifica...

    Authors: Craig Steven McLachlan
    Citation: Clinical Hypertension 2020 26:14
  19. Addressing chronic diseases is a challenge for healthcare systems worldwide, which have largely developed to deal with acute episodic care, rather than to provide organized care for people with age-long condit...

    Authors: Michael Ekholuenetale and Amadou Barrow
    Citation: Clinical Hypertension 2020 26:12
  20. Hyperuricemia, which has been considered as a cause of gout and nephrolithiasis has recently been suggested to be associated with hypertension, coronary heart disease, heart failure, atrial fibrillation, insul...

    Authors: Seung Jae Lee, Byeong Kil Oh and Ki-Chul Sung
    Citation: Clinical Hypertension 2020 26:13
  21. Hypertension, itself being a major chronic condition, is one of the most significant risk factors for premature cardiovascular diseases and mortality. Hypertension is responsible for 13% of global deaths and t...

    Authors: Mohammad Ziaul Islam Chowdhury, Meshbahur Rahman, Tanjila Akter, Tania Akhter, Arifa Ahmed, Minhajul Arifin Shovon, Zaki Farhana, Nashit Chowdhury and Tanvir C. Turin
    Citation: Clinical Hypertension 2020 26:10
  22. The incidence of hypertension is increasing worldwide and obesity is one of the most significant risk factors. Obesity can be defined by various anthropometric indices such as body mass index (BMI), waist-to-h...

    Authors: Ryuichi Kawamoto, Asuka Kikuchi, Taichi Akase, Daisuke Ninomiya and Teru Kumagi
    Citation: Clinical Hypertension 2020 26:9
  23. Antihypertensive drugs are one of the most widely used pharmacologic agent in the world and it is predominantly used in the elderly subjects. Pneumonia is the most common cause of death in the extremely old su...

    Authors: Sungha Park, Hae Young Lee, Eun Joo Cho, Ki Chul Sung, Juhan Kim, Dae-Hee Kim, Sang-Hyun Ihm, Kwang-il Kim, Il-Suk Sohn, Wook-Jin Chung, Hyeon Chang Kim, Sung Kee Ryu, Wook Bum Pyun and Jinho Shin
    Citation: Clinical Hypertension 2020 26:11
  24. Zonulin has been implicated in many metabolic disorders including hypertension and obesity. However, there is insufficient information about the involvement of zonulin in pregnancy induced hypertension (PIH) w...

    Authors: Ahmed Tijani Bawah, Henry Tornyi, Mohammed Mustapha Seini, Lincoln Toamsoma Ngambire and Francis Agyemang Yeboah
    Citation: Clinical Hypertension 2020 26:7
  25. Renal artery stenosis is a notorious cause of secondary hypertension which classically presents as chronic refractory hypertension, recurrent flash pulmonary edema or renal insufficiency after initiation of an...

    Authors: Michael Brandon Omar, William Kogler, Satish Maharaj and Win Aung
    Citation: Clinical Hypertension 2020 26:6
  26. Although dietary modification is strongly recommended for prevention and treatment of hypertension, little is known about which factors are associated with adherence to dietary guidelines. We investigated know...

    Authors: Jee-Seon Shim, Ji Eun Heo and Hyeon Chang Kim
    Citation: Clinical Hypertension 2020 26:5
  27. The Korean Society of Hypertension (KSH) revised the local guidelines for hypertension in 2018. The present study sought to evaluate the potential impact of the 2018 KSH guidelines on hypertension management s...

    Authors: Ju-Seung Kwun, Sun-Hwa Kim, Si-Hyuck Kang, Chang-Hwan Yoon, Hae-Young Lee, Kwang-Il Kim, Tae-Jin Youn, In-Ho Chae and Cheol-Ho Kim
    Citation: Clinical Hypertension 2020 26:3
  28. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) tends to increase with age and increase in proportion to body weight and height. Recent epidemiological and longitudinal cohort studies have fou...

    Authors: Jung Won Lee, Nameun Kim, Bohyun Park, Hyesook Park and Hae Soon Kim
    Citation: Clinical Hypertension 2020 26:2
  29. Hypertension is a leading cause of cardiovascular disease, stroke, and death. It affects a substantial proportion of the population worldwide, and remains underdiagnosed and undertreated.

    Authors: Gyu Chul Oh and Hyun-Jai Cho
    Citation: Clinical Hypertension 2020 26:1
  30. Although there has been a well-established association between overweight-obesity and hypertension, whether such associations are heterogeneous for South Asian populations, or for different socioeconomic group...

    Authors: Fariha Binte Hossain, Gourab Adhikary, Ariful Bari Chowdhury and Md Shajedur Rahman Shawon
    Citation: Clinical Hypertension 2019 25:28
  31. Hypertension control is a major public health concern. Daily preventive practices of the affected individual are essential for controlling blood pressure (BP). We investigated the association of diet managemen...

    Authors: Jee-Seon Shim, Sun Jae Jung and Hyeon Chang Kim
    Citation: Clinical Hypertension 2019 25:24
  32. The significance of high systolic and diastolic blood pressure remains controversial. We assessed the differences in prevalence of hypertension and its subtypes according to the different hypertension diagnost...

    Authors: So Mi Jemma Cho, Hokyou Lee and Hyeon Chang Kim
    Citation: Clinical Hypertension 2019 25:26
  33. 17α-hydroxylase deficiency is a rare autosomal recessive disorder caused by mutations in the cytochrome P450 family 17 subfamily A member 1 gene. The major clinical presentation includes hypertension, hypokale...

    Authors: Menglin Wang, Hao Wang, Haiying Zhao, Ling Li, Min Liu, Fujia Liu, Fansen Meng and Caini Fan
    Citation: Clinical Hypertension 2019 25:23
  34. Pulmonary arterial hypertension (PAH) is known as one of diseases with the worst prognosis. Recently, targeted PAH drugs have been developed and approved for use; therefore, the treatment strategy and goals ha...

    Authors: Kyung Jin Ahn, Albert Youngwoo Jang, Su Jung Park and Wook-Jin Chung
    Citation: Clinical Hypertension 2019 25:22
  35. Pulmonary arterial hypertension (PAH) is a progressive, chronic disease without curative treatment. Large registry data of these patient populations have been published, although, phenotypic variants within ea...

    Authors: Albert Youngwoo Jang, Sungseek Kim, Su Jung Park, Hanul Choi, Pyung Chun Oh, Seyeon Oh, Kyung-Hee Kim, Kye Hun Kim, Kyunghee Byun and Wook-Jin Chung
    Citation: Clinical Hypertension 2019 25:21
  36. This study was performed to compare the associations of brachial-ankle pulse wave velocity (baPWV) and central blood pressure (CBP) measurements with left ventricular (LV) geometry and diastolic function.

    Authors: Hack-Lyoung Kim, Woo-Hyun Lim, Jae-Bin Seo, Sang-Hyun Kim, Zoo-Hee Zo and Myung-A Kim
    Citation: Clinical Hypertension 2019 25:18
  37. The standardized techniques of blood pressure (BP) measurement in the clinic are emphasized and it is recommended to replace the mercury sphygmomanometer by a non-mercury sphygmomanometer. Out-of-office BP mea...

    Authors: Hae-Young Lee, Jinho Shin, Gheun-Ho Kim, Sungha Park, Sang-Hyun Ihm, Hyun Chang Kim, Kwang-il Kim, Ju Han Kim, Jang Hoon Lee, Jong-Moo Park, Wook Bum Pyun and Shung Chull Chae
    Citation: Clinical Hypertension 2019 25:20
  38. Treatment of hypertension improves cardiovascular, renal, and cerebrovascular outcomes. However, the benefit of treatment may be different according to the patients’ characteristics. Additionally, the target b...

    Authors: Kwang-il Kim, Sang-Hyun Ihm, Gheun-Ho Kim, Hyeon Chang Kim, Ju Han Kim, Hae-Young Lee, Jang Hoon Lee, Jong-Moo Park, Sungha Park, Wook Bum Pyun, Jinho Shin and Shung Chull Chae
    Citation: Clinical Hypertension 2019 25:19
  39. The Korean Society of Hypertension guideline defines hypertension as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, where the effectiveness of pharmacological treatment has been esta...

    Authors: Hyeon Chang Kim, Sang-Hyun Ihm, Gheun-Ho Kim, Ju Han Kim, Kwang-il Kim, Hae-Young Lee, Jang Hoon Lee, Jong-Moo Park, Sungha Park, Wook Bum Pyun, Jinho Shin and Shung Chull Chae
    Citation: Clinical Hypertension 2019 25:16
  40. Preeclampsia is leading causes of maternal and perinatal morbidity and mortality worldwide and it is a hypertensive disorder which usually occurs after 20 weeks of gestation. In Ethiopia, according to Ethiopia...

    Authors: Alemayehu Sayih Belay and Tofik Wudad
    Citation: Clinical Hypertension 2019 25:14
  41. The dysregulation of histone deacetylase (HDAC) protein expression or its enzyme activity is implicated in a variety of diseases. Cardiac HDAC6 and HDAC8 enzyme activity induced by deoxycorticosterone acetate ...

    Authors: Hae Jin Kee, Yuhee Ryu, Young Mi Seok, Sin Young Choi, Simei Sun, Gwi Ran Kim and Myung Ho Jeong
    Citation: Clinical Hypertension 2019 25:13

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    4.2 - 2-year Impact Factor
    1.756 - SNIP (Source Normalized Impact per Paper)
    0.999 - SJR (SCImago Journal Rank)

    2023 Speed
    18 days submission to first editorial decision for all manuscripts (Median)
    136 days submission to accept (Median)

    2023 Usage 
    400,408 downloads
    59 Altmetric mentions